Fierce Biotech May 27, 2024
Helen Floersh

OCT Global SA and Palleos Healthcare have merged under the Palleos brand name, the European contract research organizations announced in a May 27 release. Financial details were not disclosed.

“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies,” Philip Räth, Ph.D., managing director at Palleos, said in the release.

He added that the merger is also advantageous from a geographical perspective: Germany-based Palleos operates primarily in Western and Central Europe, while OCT’s territory covers eastern countries.

“Both together now...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Kroger partners with Express Scripts to expand pharmacy services
Some of the Biggest Healthcare Stories from 2024 Involved Pharmacy. What’s Next in 2025?
Insights from JP Morgan 2025: Key trends shaping the pharma industry
“Precision Med Has Evolved as Badly As I Expected” And Other Takeaways From Former FDA Commissioner At PMWC
Oral Metabolic Drug Acquired by Novo Nordisk Continues to Show Concerning Neuro Side Effects

Share This Article